In a bumper week for new biotech financings, debutante Kardigan ruled the roost with a $300 million first round that will ...
It appears the writing’s on the chalkboard for this Long Island elementary school. The West Babylon Union Free School ...
It’s a kind of control that no one has ever tried before in patients,” Tune’s chief scientific officer said Monday.
The Legend of Zelda: The Wind Waker has today had its soundtrack added to the Nintendo Music app. An impressive 133 tracks ...
Launched from a Duke University lab four years ago, the biotech startup Tune Therapeutics announced a major milestone Sunday — raising $175 million in a Series B funding round to support its first ...
Tune Therapeutics, an epigenome-editing company with origins at Duke University, has raised over $175 million in financing to advance a potential treatment for chronic hepatitis B and other diseases.